Robert B Griffith, MD in Burien, WA - General Practice

Robert B Griffith, MD is a General Practice physician based in Burien, Washington. Robert B Griffith is licensed to practice in Washington (license number MD00009417) and his current practice location is 14434 Ambaum Blvd Sw, #4, Burien, Washington. He can be reached at his office (for appointments etc.) via phone at (206) 244-9211.

NPI number for Robert B Griffith is 1750479531 and his current mailing address is 14434 Ambaum Blvd Sw, #4, Burien, Washington. He does not participate in medicare program and thus does not accept medicare assignments. His NPI Number is 1750479531.

Contact Information

	Robert B Griffith, MD
	14434 Ambaum Blvd Sw, #4, Burien, WA 98166
	(206) 244-9211
	(206) 244-6184

Physician's Profile

Full Name	Robert B Griffith
Gender	Male
Speciality	General Practice
Location	14434 Ambaum Blvd Sw, Burien, Washington
Accepts Medicare Assignments	Does not participate in Medicare Program. He may not accept medicare assignment.

NPI Data:

NPI Number: 1750479531
Provider Enumeration Date: 10/10/2006
Last Update Date: 07/08/2007

Medical Identifiers

Medical identifiers for Robert B Griffith such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1750479531	NPI	-	NPPES
1326008	Medicaid	WA

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
208D00000X	General Practice	MD00009417 (Washington)	Primary

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Robert B Griffith is NOT enrolled with medicare and thus cannot prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Robert B Griffith, MD 14434 Ambaum Blvd Sw, #4, Burien, WA 98166 Ph: (206) 244-9211	Robert B Griffith, MD 14434 Ambaum Blvd Sw, #4, Burien, WA 98166 Ph: (206) 244-9211

News Archive

Positive preclinical results of VB-201 for treatment of psoriasis presented at 2010 SID Annual Meeting

VBL Therapeutics today announced positive preclinical results evaluating VB-201 for the treatment of psoriasis. VB-201 is a first-in-class, orally administered immune response modifier expected to reduce inflammation by targeting key pro-inflammatory cytokines. Today's data suggest that VB-201 has significant anti-inflammatory properties that are active against psoriasis; an ongoing Phase 2 efficacy and safety study is currently evaluating VB-201 for the treatment of patients with psoriasis.

ERC Starting Grant to support research on how gut bacteria may affect blood pressure

The community of bacteria inhabiting our bowels, known as the gut microbiome, affects our health and immune system - in a range of different ways.

Tiny hearts may have big problems with complementary medicine

Giving supplement such as herbs, vitamins, and other natural health products to children taking Warfarin for congenital heart defects could increase their risk of clots, bleeding, and other complications, nurse practitioner Mary Bauman and Dr. Patti Massicotte told the 2008 Canadian Cardiovascular Congress, co-hosted by the Heart and Stroke Foundation and the Canadian Cardiovascular Society.

Researchers start enrolling patients for Phase II gene therapy trial for choroideremia

Following on from a successful world's first Phase I gene therapy trial for choroideremia, Professor Robert MacLaren and his team at Oxford University and the Oxford Eye Hospital at the John Radcliffe Hospital have started a Phase II trial enrolling 30 patients.

Robert B Griffith, MD - General Practice in Burien, WA